Lupeol (29) has therapeutic effects in some cancers, in addition to its inhibitory effects on NF-κB signaling described above it seems that it has the potential to inhibit several other signaling pathways, such as the Akt-dependent pathways, and this may enhance its anti-cancer properties [86]. Here, NFKB1 is linked to cancer.